PHYTONADIONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Phytonadione, and what generic alternatives are available?
Phytonadione is a drug marketed by Cipla, Dr Reddys, Glaxosmithkline, Intl Medication, Agnitio, Amneal Pharms Co, Sciegen Pharms Inc, and Zydus Lifesciences. and is included in nine NDAs.
The generic ingredient in PHYTONADIONE is phytonadione. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the phytonadione profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Phytonadione
A generic version of PHYTONADIONE was approved as phytonadione by AMNEAL PHARMS CO on May 11th, 2018.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PHYTONADIONE?
- What are the global sales for PHYTONADIONE?
- What is Average Wholesale Price for PHYTONADIONE?
Summary for PHYTONADIONE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 9 |
| Finished Product Suppliers / Packagers: | 15 |
| Raw Ingredient (Bulk) Api Vendors: | 103 |
| Clinical Trials: | 7 |
| Patent Applications: | 3,627 |
| Drug Prices: | Drug price information for PHYTONADIONE |
| What excipients (inactive ingredients) are in PHYTONADIONE? | PHYTONADIONE excipients list |
| DailyMed Link: | PHYTONADIONE at DailyMed |
Recent Clinical Trials for PHYTONADIONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Sydney | Phase 3 |
| Australasian Kidney Trials Network | Phase 3 |
| Waitemata District Health Board | Phase 3 |
Pharmacology for PHYTONADIONE
| Drug Class | Vitamin K Warfarin Reversal Agent |
| Physiological Effect | Increased Prothrombin Activity Reversed Anticoagulation Activity |
US Patents and Regulatory Information for PHYTONADIONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cipla | PHYTONADIONE | phytonadione | INJECTABLE;INJECTION | 212424-001 | Apr 22, 2022 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glaxosmithkline | PHYTONADIONE | phytonadione | INJECTABLE;INJECTION | 084060-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Cipla | PHYTONADIONE | phytonadione | INJECTABLE;INJECTION | 214596-002 | Apr 22, 2022 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Zydus Lifesciences | PHYTONADIONE | phytonadione | TABLET;ORAL | 210189-001 | Feb 20, 2019 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Intl Medication | PHYTONADIONE | phytonadione | INJECTABLE;INJECTION | 083722-001 | Approved Prior to Jan 1, 1982 | BP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
